AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
#35 – Oral Beta-Lactams, Are We Serious?
Breakpoints
How to Use Oral Beta Lactams to Improve Treatment Decisions
Jesse: I have a couple of ideas, research ideas that maybe some people can jump on. One would be pharmacokinetic models for a wider variety of patients and doses of these drugs. The other one is correlating the susceptibility that we receive to the oral cephalosporins that we'd actually be using. We talked about how you might just get a cepHalosene susceptibility or a cep Halosene MIC. And then we're extrapolating that to cep halosene or extrapolating it to cepyroxine. So those are my pearls. Thank you, Jesse, for all these wonderful ideas on research and giving inspiring some
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode